Mount Vernon, NH, United States of America

Melissa Ashlock

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Melissa Ashlock: Innovator in Autoimmune Disease Treatment

Introduction

Melissa Ashlock is a prominent inventor based in Mount Vernon, NH (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of autoimmune and inflammatory diseases. With a total of two patents to her name, Ashlock's work is paving the way for innovative therapeutic solutions.

Latest Patents

Ashlock's latest patents focus on histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases. The inventions relate to compositions and methods that comprise histidyl-tRNA synthetase polypeptides or other specific blocking agents. These innovations aim to provide effective treatments for autoimmune diseases and other inflammatory conditions, including those associated with Jo-1 antibodies.

Career Highlights

Throughout her career, Melissa Ashlock has worked with notable companies in the biotechnology sector. She has been associated with Atyr Pharma, Inc. and Pangu Biopharma Limited, where she has contributed her expertise in developing therapeutic solutions. Her work has garnered attention for its potential impact on patient care and treatment options.

Collaborations

Some of her notable coworkers include Kyle P Chiang and Elisabeth Gardiner. Their collaborative efforts have further advanced the research and development of innovative treatments in the field.

Conclusion

Melissa Ashlock's contributions to the field of biotechnology and her innovative patents highlight her commitment to improving the treatment of autoimmune diseases. Her work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…